A detailed history of Dimensional Fund Advisors LP transactions in Xencor Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,399,235 shares of XNCR stock, worth $32.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,399,235
Previous 1,459,427 4.12%
Holding current value
$32.3 Million
Previous $27.6 Million 1.85%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$15.7 - $21.65 $945,014 - $1.3 Million
-60,192 Reduced 4.12%
1,399,235 $28.1 Million
Q2 2024

Aug 09, 2024

BUY
$18.21 - $24.5 $1.6 Million - $2.16 Million
87,979 Added 6.42%
1,459,427 $27.6 Million
Q1 2024

May 10, 2024

BUY
$18.65 - $26.52 $1.72 Million - $2.45 Million
92,371 Added 7.22%
1,371,448 $30.4 Million
Q4 2023

Feb 07, 2024

SELL
$16.53 - $21.42 $2.85 Million - $3.69 Million
-172,270 Reduced 11.87%
1,279,077 $27.2 Million
Q3 2023

Nov 09, 2023

SELL
$20.08 - $25.39 $2.55 Million - $3.22 Million
-126,899 Reduced 8.04%
1,451,347 $29.2 Million
Q2 2023

Aug 09, 2023

BUY
$24.77 - $29.9 $732,820 - $884,591
29,585 Added 1.91%
1,578,246 $39.4 Million
Q1 2023

May 12, 2023

BUY
$25.95 - $36.95 $7.32 Million - $10.4 Million
282,131 Added 22.28%
1,548,661 $43.2 Million
Q4 2022

Feb 09, 2023

BUY
$24.79 - $30.86 $2.58 Million - $3.21 Million
103,991 Added 8.95%
1,266,530 $33 Million
Q3 2022

Nov 10, 2022

BUY
$24.62 - $32.44 $1.01 Million - $1.33 Million
40,862 Added 3.64%
1,162,539 $30.2 Million
Q2 2022

Aug 12, 2022

BUY
$19.74 - $29.01 $3.85 Million - $5.66 Million
194,968 Added 21.04%
1,121,677 $30.7 Million
Q1 2022

May 13, 2022

BUY
$26.68 - $41.63 $2.17 Million - $3.39 Million
81,482 Added 9.64%
926,709 $24.7 Million
Q4 2021

Feb 09, 2022

BUY
$33.67 - $43.44 $1.53 Million - $1.97 Million
45,409 Added 5.68%
845,227 $33.9 Million
Q3 2021

Nov 12, 2021

SELL
$30.65 - $35.68 $6.14 Million - $7.15 Million
-200,276 Reduced 20.03%
799,818 $26.1 Million
Q2 2021

Aug 12, 2021

BUY
$34.33 - $44.68 $2.27 Million - $2.95 Million
66,096 Added 7.08%
1,000,094 $34.5 Million
Q1 2021

May 14, 2021

BUY
$40.81 - $53.88 $2.84 Million - $3.75 Million
69,511 Added 8.04%
933,998 $40.2 Million
Q4 2020

Feb 25, 2021

BUY
$36.63 - $47.63 $31.7 Million - $41.2 Million
864,487 New
864,487 $37.7 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.